Humans and AI will soon design highly developable, epitope-specific antibodies
Our Observations
- AI companies either scale with compute or don't scale at all
- Proteins are dynamic structures, but existing data is biased toward static structures
- Antibody models ought to optimize the underlying biophysics else fail to generalize outside the narrow slice of observed antibody space